» Articles » PMID: 28962283

Inactivation of 15 in Chronic Arsenic Poisoning Cases

Overview
Journal Toxicol Rep
Date 2017 Oct 1
PMID 28962283
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Arsenic exposure from burning high arsenic-containing coal has been associated with human skin lesion and cancer. However, the mechanisms of arsenic-related carcinogenesis are not fully understood. Inactivation of critical tumor suppression genes by epigenetic regulation or genetic modification might contribute to arsenic-induced carcinogenicity. This study aims to clarify the correlation between arsenic pollution and functional defect of gene in arsenic exposure residents from a region of Guizhou Province, China. To this end, 103 arsenic exposure residents and 105 control subjects were recruited in this study. The results showed that the exposure group exhibited higher levels of urinary and hair arsenic compared with the control group (55.28 28.87 μg/L, 5.16 1.36 μg/g). Subjects with higher arsenic concentrations are more likely to have methylation and gene deletion ( = 4.28, = 0.04 and = 4.31, = 0.04). We also found that the degree of hypermethylation and gene deletion occurred at higher incidence in the poisoning cases with skin cancer (3.7% and 14.81% in non-skin cancer group, 41.18% and 47.06 in skin cancer group), and were significantly associated with the stage of skin lesions ( = 12.82, < 0.01 and = 7.835, = 0.005). These observations indicate that inactivation of through genetic alteration or epigenetic modification is a common event that is associated with arsenic exposure and the development of arsenicosis.

Citing Articles

Aberrant DNA Methylation of Two Tumor Suppressor Genes, and , after Chronic Occupational Exposure to Low Level of Benzene.

Jamebozorgi I, Majidizadeh T, Pouryagoub G, Mahjoubi F Int J Occup Environ Med. 2018; 9(3):145-151.

PMID: 29995020 PMC: 6466977. DOI: 10.15171/ijoem.2018.1317.


Risk assessment of exposure to particulate output of a demolition site.

Brown A, Barrett J, Robinson H, Potgieter-Vermaak S Environ Geochem Health. 2015; 37(4):675-87.

PMID: 26173774 DOI: 10.1007/s10653-015-9747-3.

References
1.
Cohen S, Ohnishi T, Arnold L, Le X . Arsenic-induced bladder cancer in an animal model. Toxicol Appl Pharmacol. 2006; 222(3):258-63. DOI: 10.1016/j.taap.2006.10.010. View

2.
Bhattacharjee P, Banerjee M, Giri A . Role of genomic instability in arsenic-induced carcinogenicity. A review. Environ Int. 2013; 53:29-40. DOI: 10.1016/j.envint.2012.12.004. View

3.
Mass M, Wang L . Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res. 1997; 386(3):263-77. DOI: 10.1016/s1383-5742(97)00008-2. View

4.
Reichard J, Puga A . Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics. 2010; 2(1):87-104. PMC: 2877392. DOI: 10.2217/epi.09.45. View

5.
Ortega S, Malumbres M, Barbacid M . Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta. 2002; 1602(1):73-87. DOI: 10.1016/s0304-419x(02)00037-9. View